• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期透析患者心力衰竭的诊断与管理

Diagnosis and Management of Heart Failure in Long-Term Dialysis Patients.

作者信息

Abdo Ashraf S

机构信息

Medical Service, G.V. (Sonny) Montgomery Veterans Affairs Medical Center, Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA.

出版信息

Curr Heart Fail Rep. 2017 Oct;14(5):404-409. doi: 10.1007/s11897-017-0354-8.

DOI:10.1007/s11897-017-0354-8
PMID:28779281
Abstract

PURPOSE OF REVIEW

Development of congestive heart failure as a manifestation of various cardiovascular ailments is not only an adverse prognostic factor for patients on long-term dialysis but its presence at the initiation of hemodialysis is another independent indicator of higher mortality.

RECENT FINDINGS

The literature reviewed included the most recent studies that assessed the prevalence, incidence, and risk factors associated with dialysis in the setting of congestive heart failure. Improving outcomes for patients with heart failure in long-term dialysis continues to constitute a challenge due to the complexity of these illnesses and the lack of clear consensus to guide diagnosis and management.

摘要

综述目的

充血性心力衰竭作为各种心血管疾病的一种表现形式,不仅是长期透析患者的不良预后因素,而且在血液透析开始时出现也是死亡率较高的另一个独立指标。

最新发现

所综述的文献包括评估充血性心力衰竭背景下透析相关的患病率、发病率和危险因素的最新研究。由于这些疾病的复杂性以及缺乏指导诊断和管理的明确共识,改善长期透析患者心力衰竭的预后仍然是一项挑战。

相似文献

1
Diagnosis and Management of Heart Failure in Long-Term Dialysis Patients.长期透析患者心力衰竭的诊断与管理
Curr Heart Fail Rep. 2017 Oct;14(5):404-409. doi: 10.1007/s11897-017-0354-8.
2
Lower risk of de novo congestive heart failure in peritoneal dialysis patients compared with hemodialysis patients.与血液透析患者相比,腹膜透析患者新发充血性心力衰竭的风险更低。
Int J Cardiol. 2017 Feb 15;229:123. doi: 10.1016/j.ijcard.2016.10.066. Epub 2016 Oct 27.
3
Current perspectives on diagnosis of heart failure in long-term dialysis patients.慢性透析患者心力衰竭诊断的当前观点。
Am J Kidney Dis. 2011 Feb;57(2):308-19. doi: 10.1053/j.ajkd.2010.07.019. Epub 2010 Nov 5.
4
Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.透析患者的充血性心力衰竭:患病率、发病率、预后及危险因素
Kidney Int. 1995 Mar;47(3):884-90. doi: 10.1038/ki.1995.132.
5
Treatment of heart failure in long-term dialysis patients: a reappraisal.长期透析患者心力衰竭的治疗:再评价。
Am J Kidney Dis. 2011 May;57(5):760-72. doi: 10.1053/j.ajkd.2011.01.014. Epub 2011 Feb 23.
6
High-output heart failure: how to define it, when to treat it, and how to treat it.高心输出量心力衰竭:如何定义、何时治疗以及如何治疗。
Semin Nephrol. 2012 Nov;32(6):551-7. doi: 10.1016/j.semnephrol.2012.10.006.
7
Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease.终末期肾病患者慢性心力衰竭行血液透析与腹膜透析的风险比较
Int J Cardiol. 2016 Nov 15;223:360. doi: 10.1016/j.ijcard.2016.08.217. Epub 2016 Aug 13.
8
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
9
Do cardiac troponins provide prognostic insight in hemodialysis patients?心肌肌钙蛋白能否为血液透析患者提供预后信息?
Can J Cardiol. 2003 Jul;19(8):907-11.
10
Mortality after Renal Allograft Failure and Return to Dialysis.肾移植失败并恢复透析后的死亡率。
Am J Nephrol. 2017;45(2):180-186. doi: 10.1159/000455015. Epub 2017 Jan 21.

引用本文的文献

1
Application of transthoracic echocardiography to assess the dynamic evolution of early cardiac damage induced by abdominal aorta-inferior vena cava fistula in female rats with chronic renal failure.应用经胸超声心动图评估慢性肾功能衰竭雌性大鼠腹主动脉-下腔静脉瘘所致早期心脏损伤的动态演变。
PLoS One. 2025 Aug 22;20(8):e0324951. doi: 10.1371/journal.pone.0324951. eCollection 2025.
2
Impact of dialysis modality choice on the survival of end-stage renal disease patients with congestive heart failure in southern China: A retrospective cohort study.透析方式选择对中国南方终末期肾病合并充血性心力衰竭患者生存的影响:一项回顾性队列研究。
Front Med (Lausanne). 2022 Oct 17;9:898650. doi: 10.3389/fmed.2022.898650. eCollection 2022.
3

本文引用的文献

1
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.维持性血液透析患者的心血管影响:临床管理考量
Int J Cardiol. 2017 Apr 1;232:12-23. doi: 10.1016/j.ijcard.2017.01.015. Epub 2017 Jan 4.
2
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.晚期及终末期肾病患者心血管疾病的诊断与管理
J Am Heart Assoc. 2016 Aug 4;5(8):e003648. doi: 10.1161/JAHA.116.003648.
3
Prognostic Utility of Calcium Scoring as an Adjunct to Stress Myocardial Perfusion Scintigraphy in End-Stage Renal Disease.
Clinical Prediction of Heart Failure in Hemodialysis Patients: Based on the Extreme Gradient Boosting Method.
血液透析患者心力衰竭的临床预测:基于极端梯度提升法
Front Genet. 2022 Apr 26;13:889378. doi: 10.3389/fgene.2022.889378. eCollection 2022.
4
Advance Care Planning Documentation and Intensity of Care at the End of Life for Adults With Congestive Heart Failure, Chronic Kidney Disease, and Both Illnesses.充血性心力衰竭、慢性肾脏病以及同时患有这两种疾病的成年人的临终关怀计划文件记录和护理强度。
J Pain Symptom Manage. 2022 Feb;63(2):e168-e175. doi: 10.1016/j.jpainsymman.2021.07.030. Epub 2021 Aug 4.
5
Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.当代严重急性肾损伤和难治性心肾综合征的管理:美国心脏病学会理事会观点。
J Am Coll Cardiol. 2020 Sep 1;76(9):1084-1101. doi: 10.1016/j.jacc.2020.06.070.
6
Screening of multiple hemoprotein-specific aptamers and their applications for the binding, quantification, and extraction of hemoproteins in a microfluidic system.多种血蛋白特异性适配体的筛选及其在微流控系统中对血蛋白的结合、定量和提取中的应用。
Biomicrofluidics. 2020 Apr 13;14(2):024110. doi: 10.1063/1.5141871. eCollection 2020 Mar.
钙评分作为终末期肾病患者负荷心肌灌注显像辅助手段的预后价值
Am J Cardiol. 2016 May 1;117(9):1387-96. doi: 10.1016/j.amjcard.2016.02.003. Epub 2016 Feb 17.
4
Heart failure in patients with chronic kidney disease: a systematic integrative review.慢性肾病患者的心力衰竭:一项系统综合综述
Biomed Res Int. 2014;2014:937398. doi: 10.1155/2014/937398. Epub 2014 May 15.
5
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.慢性肾脏病的评估与管理:肾脏病:改善全球预后 2012 临床实践指南概要。
Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
6
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.终末期肾病患者的多支冠状动脉旁路移植术与经皮冠状动脉介入治疗。
J Am Soc Nephrol. 2012 Dec;23(12):2042-9. doi: 10.1681/ASN.2012060554.
7
Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease.老年慢性肾脏病患者经皮冠状动脉血运重建术与外科冠状动脉血运重建术治疗后的死亡风险和终末期肾病风险。
Circulation. 2012 Sep 11;126(11 Suppl 1):S164-9. doi: 10.1161/CIRCULATIONAHA.111.083568.
8
Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice.慢性肾脏病和终末期肾病患者的心血管植入式电子设备导线:综述与实践建议
Semin Dial. 2013 Jan-Feb;26(1):114-23. doi: 10.1111/j.1525-139X.2012.01103.x. Epub 2012 Aug 15.
9
Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease.血管紧张素 II 介导的慢性肾脏病左心室异常。
J Investig Med. 2012 Jun;60(5):785-91. doi: 10.2310/JIM.0b013e318250b101.
10
FGF23 and PTH--double agents at the heart of CKD.成纤维细胞生长因子23和甲状旁腺激素——慢性肾脏病的核心双重因素
Nephrol Dial Transplant. 2012 May;27(5):1715-20. doi: 10.1093/ndt/gfs050. Epub 2012 Mar 23.